Hypervirulent M. tuberculosis W/Beijing strains upregulate Type I IFNs and increase expression of negative regulators of the jak-stat pathway

Journal of Interferon and Cytokine Research

Volumn 25, Issue 11, 2005, Pages 694-701

  Manca, Claudia ^a   Tsenova, Liana ^a   Freeman, Sherry ^a   Barczak, Amy K ^b   Tovey, Michael ^c   Murray, Peter J ^d   Barry III, Clifton ^b   Kaplan, Gilla ^a  

^a PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c INSTITUT ANDRÉ LWOFF   (France)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CD45 ANTIGEN; INTERFERON; INTERFERON RECEPTOR; INTERLEUKIN 12; JANUS KINASE; MESSENGER RNA; PROTEIN PTPN1; PROTEIN PTPNS1; PROTEIN TYROSINE PHOSPHATASE; STAT PROTEIN; STAT1 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 4; SUPPRESSOR OF CYTOKINE SIGNALING 5; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TH1 CELL; WILD TYPE;

ANIMALS; ANTIGENS, CD45; CARRIER PROTEINS; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, BACTERIAL; JANUS KINASE 1; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MICE; MICE, KNOCKOUT; MYCOBACTERIUM TUBERCULOSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN-TYROSINE KINASES; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; T-LYMPHOCYTES; TH1 CELLS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; VIRULENCE;

ANIMALIA; BACTERIA (MICROORGANISMS); MURINAE; MYCOBACTERIUM TUBERCULOSIS;

EID: 29444432905     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2005.25.694     Document Type: Article

References (37)

1. Hope JC, Thom ML, McCormick PA, Howard CJ. Interaction of antigen-presenting cells with mycobacteria. Vet. Immunol. Immunopathol. 2004;100:187-195.
2. Tobian AA, Potter NS, Ramachandra L, Pai RK, Convery M, Boom WH, Harding CV. Alternate class I MHC antigen processing is inhibited by toll-like receptor signaling pathogen-associated molecular patterns: Mycobacterium tuberculosis 19-kDa lipoprotein, CpG DNA, and lipopolysaccharide. J. Immunol. 2003;171:1413-1422.
3. Saunders BM, Cooper AM. Restraining mycobacteria: role of granulomas in mycobacterial infections. Immunol. Cell Biol. 2000; 78:334-341.
4. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 1993;178: 2249-2254.
5. Denis M. Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates. Cell. Immunol. 1991;132:150-157.
6. Manca C, Tsenova L, Barry CE III, Bergtold A, Freeman S, Haslett PA, Musser JM, Freedman VH, Kaplan G. Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro but is not more virulent than other clinical isolates. J. Immunol. 1999;162:6740-6746.
7. Manca C, Tsenova L, Bergtold A, Freeman S, Tovey M, Musser JM, Barry CE III, Freedman VH, Kaplan G. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /beta. Proc. Natl. Acad. Sci. USA 2001;98: 5752-5757.
8. Cooper AM, Pearl JE, Brooks JV, Ehlers S, Orme IM. Expression of the nitric oxide synthase 2 gene is not essential for early control of Mycobacterium tuberculosis in the murine lung. Infect. Immun. 2000;68:6879-6882.
9. Valway SE, Sanchez MP, Shinnick TF, Orme I, Agerton T, Hoy D, Jones JS, Westmoreland H, Onorato IM. An outbreak involving extensive transmission of a virulent strain of Mycobacterium tuberculosis. N. Engl. J. Med. 1998;338:633-639.
10. Hussain S, Zwilling BS, Lafuse WP. Mycobacterium avium infection of mouse macrophages inhibits IFN-gamma Janus kinase-Stat signaling and gene induction by down-regulation of the IFN-gamma receptor. J. Immunol. 1999;163:2041-2048.
11. Ting LM, Kim AC, Cattamanchi A, Ernst JD. Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of Stat1. J. Immunol. 1999;163:3898-3906.
12. Imai K, Kurita-Ochiai T, Ochiai K. Mycobacterium bovis bacillus Calmette-Guerin infection promotes SOCS induction and inhibits IFN-gamma-stimulated Jak/Stat signaling in J774 macrophages. FEMS Immunol. Med. Microbiol. 2003;39:173-180.
13. Bifani PJ, Mathema B, Liu Z, Moghazeh SL, Shopsin B, Tempalski B, Driscol J, Frothingham R, Musser JM, Alcabes P, Kreiswirth BN. Identification of a W variant outbreak of Mycobacterium tuberculosis via population-based molecular epidemiology. JAMA 1999;282:2321-2327.
14. Muller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkernagel RM, Aguet M. Functional role of type I and type II interferons in antiviral defense. Science 1994;264:1918-1921.
15. Tsenova L, Moreira LA, Party E, Freedman VH, Kaplan G. Aerosol infection of mice with mycobacteria using a nose-only exposure devise. J. ABSA 1997;2:20.
16. Gresser I, Maury C, Kaido T, Bandu MT, Tovey MG, Maunoury MT, Fantuzzi L, Gessani S, Greco G, Belardelli F. The essential role of endogenous IFN alpha/beta in the anti-metastatic action of sensitized T lymphocytes in mice injected with Friend erythroleukemia cells. Int. J. Cancer 1995;63:726-731.
17. Laochumroonvorapong P, Wang J, Liu CC, Ye W, Moreira AL, Elkon KB, Freedman VH, Kaplan G. Perform, a cytotoxic molecule which mediates cell necrosis, is not required for the early control of mycobacterial infection in mice. Infect. Immun. 1997; 65:127-132.
18. Caruso AM, Serbina N, Klein E, Triebold K, Bloom BR, Flynn JL. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. J. Immunol. 1999;162:5407-5416.
19. Biron CA. Interferons alpha and beta as immune regulators-a new look. Immunity 2001;14:661-664.
20. Bogdan C. The function of type I interferons in antimicrobial immunity. Curr. Opin. Immunol. 2000;12:419-424.
21. Decker T, Stockinger S, Karaghiosoff M, Muller M, Kovarik P. IFNs and STATs in innate immunity to microorganisms. J. Clin. Invest. 2002;109:1271-1277.
22. Biron C, Sen GC. Interferons and other cytokines. In: Knipe D, Howley P, Griffin D, Lamb R, Martin M, Straus S, eds. Fields Virology. Philadelphia: Lippincott, Williams & Wilkins; 2001:321-351.
23. Nguyen KB, Cousens LP, Doughty LA, Pien GC, Durbin JE, Biron CA. Interferon alpha/beta-mediated inhibition and promotion of interferon gamma: Stat1 resolves a paradox. Nat. Immunol. 2000; 1:70-76.
24. Cousens LP, Peterson R, Hsu S, Dorner A, Altman JD, Ahmed R, Biron CA. Two roads diverged: interferon alpha/beta- and interleukin 12-mediated pathways in promoting T cell interferon gamma responses during viral infection. J. Exp. Med. 1999;189: 1315-1328.
25. Cousens LP, Orange JS, Su HC, Biron CA. Interferon-alpha/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection. Proc. Natl. Acad. Sci. USA 1997;94:634-639.
26. O'Connell RM, Saha SK, Vaidya SA, Bruhn KW, Miranda GA, Zarnegar B, Perry AK, Nguyen BO, Lane TF, Taniguchi T, Miller JF, Cheng G. Type I interferon production enhances susceptibility to Listeria monocytogenes infection. J. Exp. Med. 2004;200: 437-445.
27. Bouchonnet F, Boechat N, Bonay M, Hance AJ. Alpha/beta interferon impairs the ability of human macrophages to control growth of Mycobacterium bovis BCG. Infect. Immun. 2002;70:3020-3025.
28. Mattner J, Schindler H, Diefenbach A, Rollinghoff M, Gresser I, Bogdan C. Regulation of type 2 nitric oxide synthase by type I interferons in macrophages infected with Leishmania major. Eur. J. Immunol. 2000;30:2257-2267.
29. Mariotti S, Teloni R, Iona E, Fattorini L, Romagnoli G, Gagliardi MC, Orefici G, Nisini R. Mycobacterium tuberculosis diverts alpha interferon-induced monocyte differentiation from dendritic cells into immunoprivileged macrophage-like host cells. Infect. Immun. 2004;72:4385-4392.
30. Auerbuch V, Brockstedt DG, Meyer-Morse N, O'Riordan M, Portnoy DA. Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes. J. Exp. Med. 2004;200:527-533.
31. Krebs DL, Hilton DJ. SOCS proteins: negative regulators of cytokine signaling. Stem Cells 2001;19:378-387.
32. Kisseleva T, Bhattacharya S, Braunstein J, Schindler CW. Signaling through the Jak-Stat pathway, recent advances and future challenges. Gene 2002;285:1-24.
33. Gingras S, Parganas E, de Pauw A, Ihle JN, Murray PJ. Re-examination of the role of SOCS1 in the regulation of toll-like receptor signaling. J. Biol. Chem. 2004;279:54702-54707.
34. Kendall SL, Rison SC, Movahedzadeh F, Frita R, Stoker NG. What do microarrays really tell us about M. tuberculosis? Trends Microbiol. 2004;12:537-544.
35. Nau GJ, Richmond JF, Schlesinger A, Jennings EG, Lander ES, Young RA. Human macrophage activation programs induced by bacterial pathogens. Proc. Natl. Acad. Sci. USA 2002;99:1503-1508.
36. Reed MB, Domenech P, Manca C, Su H, Barczak AK, Kreiswirth BN, Kaplan G, Barry CE III. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 2004;431:84-87.
37. Manca C, Reed MB, Freeman S, Mathema B, Kreiswirth B, Barry CE III, Kaplan G. Differential monocyte activation underlies strain-specific Mycobacterium tuberculosis pathogenesis. Infect. Immun. 2004;72:5511-5514.